Study of intrauterine device insertions and clinical performance in nulliparous women

Study of intrauterine device insertions and clinical

performance in nulliparous women

A. Brockmeyer and M. Kishen

Abacus Clinics, Liverpool, United Kingdom

Background There is increased interest in intrauterine

devices (IUD) from nulliparous women. The reasons include concerns about

potential side-effects or perceived long term risks of hormonal contraception.

Several studies have proven the efficacy and safety of standard IUDs. However,

there are no studies about acceptability, removal rates for pain and bleeding

and the rate of spontaneous expulsions of the standard IUDs and the IUS

routinely used in the UK in nulliparous women.

Objectives to assess experience of IUD/IUS fitting and

use by nulliparous women.

Methodology This pilot is a prospective study conducted

at the main sexual health clinic, Central Abacus, in Liverpool, UK. Nulliparous

women having IUD/IUS insertions were recruited. A sexual history was taken and

testing for sexually transmitted diseases (STI) carried out if appropriate. A

questionnaire was filled out at the time of IUD/IUS insertion, indicating any

problems and documenting the client’s experience of the procedure. The women

agreed to be contacted by postal questionnaire or by phone three months and one

year after insertion.

Results A total of 118 women were recruited between May

and October 2005. Of these 112 had an IUD/IUS fitted. 35 women (31.2%) had a T

Safe Cu 380A, 53 women (47.3%) a Nova T, 14 women (12.5%) a GyneFix device, 9

women (8.0%) a Mirena and 1 woman (0.9%) a Multiload device. There were 2 failed

insertions (1.8%). 27 women (24%) had local anaesthesia. In 41% of IUD fittings

the clinicians found the fitting procedure easier than expected. The majority of

women experienced the fitting procedure to be less painful than expected. The

results of the three month follow-up will be presented at the conference.

Conclusion IUD/IUS fittings are well tolerated by

nulliparous women. The supports the National Institute for Clinical Excellence (NICE)

guidelines of 2005 that state that all women should be given a full choice of

methods including the long acting methods like the IUD/IUS.

Scroll to Top